BABU, P. B. RAMESH and NIVEDHITA, S. and MANIKANDAN, A. and SHARON, N. S. and BALASHANMUGAM, P. (2022) REVIEW ON APPLICABILITY OF mTOR INHIBITOR DOCKING SCORE ANALYSIS METHODS IN DRUG DEVELOPMENT OF LUNG CANCER. Journal of Biochemistry International, 9 (4). pp. 28-34. ISSN 2454-4760
Full text not available from this repository.Abstract
Protein kinases have been broadly considered as significant class of target in cancer therapeutics. The mammalian target of rapamycin (mTOR) belongs to a group of protein kinases regulating cell growth and protein synthesis. Rapamycin, a natural antifungal antibiotic, can that inhibit protein kinases by partner with its intracellular receptor FKBP12. The FKBP12-rapamycin complex ties straight forwardly to the FKBP12-Rapamycin Binding (FRB) space of mTOR. Side effects in patients consuming rapamycin include: severe mood swings, small purple spots over the body retention, face allergy and anxiety. Based on recent literatures, it is understood that drug like molecules from drug bank were used to screen for potential inhibitors by docking into the active site of mTOR. A few studies used in silico tool like GLIDE, which yielded useful information about several docked structures. The drug like molecules which were complexed with mTOR could be subjected to molecular simulation studies with molecules like DB00094, which was previously reported as fertility agent targeting follicle stimulating hormone receptor. Recent literature studies have demonstrated progress in identifying mTOR drug targets in treating lung cancers and in this paper we have updated the docking score methods using in silico tools.
Item Type: | Article |
---|---|
Subjects: | Research Scholar Guardian > Biological Science |
Depositing User: | Unnamed user with email support@scholarguardian.com |
Date Deposited: | 20 Nov 2023 03:51 |
Last Modified: | 20 Nov 2023 03:51 |
URI: | http://science.sdpublishers.org/id/eprint/2145 |